Free Newsletter
Study: Lilly bone drug boosts fracture-healing
A new study could eventually boost Eli Lilly's osteoporosis drug Forteo. Researchers found that the bone med can jump-start healing of problematic fractures, making elderly patients' bones mend as if they were young again.
In a study of 145 patients with fractures that had gone unhealed for six months or more, 93 percent saw "significant healing" and pain control after eight to 12 weeks of Forteo therapy, according to a release. That study prompted an NIH-funded follow-up which is now underway--and researchers say their preliminary data appears to support Forteo's ablity to help stubborn fractures heal.
Some doctors are already using Forteo off-label to speed fracture-mending, researchers said. But if research proves that it's effective for hard-to-heal breaks such as pelvic fractures and spinal fractures, it could be adopted more broadly.
- check out the University of Rochester release
- see the HealthDay story in the Los Angeles Times
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: